Back
Day Range
$9.44
$10.00
52-Week Range
$5.01
$11.97
Volume
4,462,562
50D / 200D Avg
$9.23
/
$7.97
Prev Close
$9.62
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 3.6 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.8 |
| Net Margin % | 39.2 | 3.9 |
| Rev Growth 5Y % | 54.4 | 10.0 |
| D/E | — | 0.2 |
Key Takeaways
Revenue grew 54.42% annually over 5 years — strong growth
Net margin of 39.19% shows strong profitability
Negative free cash flow of -250.20M
P/E of 3.60 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10.27%
Capital efficient — spends only 0.49% of revenue on capex
Growth
Revenue Growth (5Y)
54.42%
Revenue (1Y)64.69%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC348.97%
Net Margin39.19%
Op. Margin50.14%
Safety
Debt / Equity
N/A
Current Ratio2.13
Interest Coverage24.98
Valuation
P/E Ratio
3.60
P/B RatioN/A
EV/EBITDA2.83
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 64.69% | Revenue Growth (3Y) | 42.10% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 54.42% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.12B | Net Income (TTM) | 440.30M |
| ROE | N/A | ROA | 37.42% |
| Gross Margin | 93.67% | Operating Margin | 50.14% |
| Net Margin | 39.19% | Free Cash Flow (TTM) | -250.20M |
| ROIC | 348.97% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.13 |
| Interest Coverage | 24.98 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 3.60 | P/B Ratio | N/A |
| P/S Ratio | 1.41 | PEG Ratio | -0.01 |
| EV/EBITDA | 2.83 | Dividend Yield | 0.00% |
| Market Cap | 1.58B | Enterprise Value | 1.59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.12B | 682.16M | 556.38M | 1.60B | 197.58M |
| Net Income | 440.30M | -187.50M | -545.06M | -657.94M | -1.74B |
| EPS (Diluted) | 2.54 | -1.23 | -5.41 | -8.42 | -23.44 |
| Gross Profit | 1.05B | 479.42M | 212.61M | 696.31M | 197.58M |
| Operating Income | 563.27M | -248.93M | -566.51M | -644.74M | -1.69B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.18B | 1.56B | 1.80B | 2.26B | 2.58B |
| Total Liabilities | 1.30B | 2.18B | 2.51B | 2.89B | 2.93B |
| Shareholders' Equity | -127.75M | -623.84M | -716.93M | -634.08M | -351.67M |
| Total Debt | 248.81M | 230.42M | 229.08M | 549.78M | 453.99M |
| Cash & Equivalents | 240.63M | 530.23M | 568.51M | 1.34B | 1.52B |
| Current Assets | 978.28M | 1.13B | 1.14B | 1.70B | 2.16B |
| Current Liabilities | 459.95M | 1.15B | 1.64B | 2.46B | 2.39B |